In 1863, a Corsican named Angelo Mariani infused South American coca leaves in Bordeaux wine and created a product that for the next half-century would simultaneously be medicine, tonic, stimulant, and object of advertising cult. This is not a story about drugs, but about a world where the boundary between pharmacy, wine cellar, and doctor's office did not yet exist—and about how that boundary came into being.
In the mid-19th century, the pharmaceutical market resembled a medieval fair: no one required listing ingredients, no one verified claims, no one distinguished between "medicine" and "beverage." Patent medicines were sold through pharmacies, newspaper ads, and traveling salesmen. Opium went into children's teething syrups. Cocaine was advertised as a remedy for toothache. Alcohol was considered a universal solvent—for chemical substances and social awkwardness alike.
Angelo Mariani, a chemist and merchant from Corsica, understood a simple thing: ethanol is an excellent extractant for alkaloids. Coca leaves contained cocaine, but chewing them was unfamiliar in Europe. Infusing them in wine—that was different. Bordeaux wine provided a respectable base, a familiar taste, and its own psychoactive effect. Cocaine enhanced the action of alcohol, alcohol masked the bitterness of coca. The result was a product you could drink with dinner, prescribe for exhaustion, and recommend to singers before a performance.
Vin Mariani contained 6 mg of cocaine per ounce for the French market and 7.2 mg for export. This wasn't a random number: Mariani experimented with concentration, seeking a balance between noticeable effect and absence of obvious intoxication. The dose was sufficient to invigorate, but insufficient to cause panic or tremors. In an era when morphine was sold freely and absinthe was considered an intellectual's drink, this looked moderate.
Mariani didn't invent cocaine and didn't discover coca leaves. He invented packaging: a bottle with a label, where chemistry became a brand and an alkaloid became a promise. The product was positioned as a remedy for "nervous exhaustion, overwork, loss of appetite"—diagnoses that in the 19th century covered everything from depression to tuberculosis. Doctors prescribed Vin Mariani because it worked: patients felt a surge of strength. No one asked at whose expense.
Mariani understood what modern marketing would rediscover a century later: people believe not chemistry, but authorities. He collected testimonials—thousands of testimonials—from artists, writers, military men, politicians. Sarah Bernhardt praised Vin Mariani for strengthening her voice. Jules Verne assured readers that the wine prolonged life and that it was "marvelous." Thomas Edison, Émile Zola, Queen Victoria—the names multiplied, turning the product into a symbol of success.
The loudest trophy was Pope Leo XIII. Mariani claimed the pontiff awarded him a gold medal and permitted use of his image in advertising. Posters exist showing the Pope holding a glass of Vin Mariani. Letters from the Vatican exist, written on official letterhead. But here begins a zone where advertising blurs fact: a thank-you letter from the papal secretary is not official endorsement by the Holy See. The medal may have been awarded personally, but that didn't make the wine a church sacrament.
Mariani didn't lie outright. He used half-tones: a photograph of the Pope next to a bottle, a quote without context, a hint instead of an assertion. In an era when advertising wasn't regulated, this worked flawlessly. People saw the Pope and thought: if Leo XIII drinks Vin Mariani, it must be blessed. No one checked whether he drank it at all.
Mariani published albums with portraits of celebrities and their testimonials. These books were distributed to doctors, displayed in pharmacies, gifted to influential clients. This wasn't just advertising—it was an encyclopedia of trust. Each new name reinforced the previous ones. A snowball effect: if so many people praise a product, it must work.
The question of whether it worked as the advertising promised didn't concern anyone. Cocaine really did elevate mood and performance. Alcohol relieved anxiety. Together they created a sense of well-being easily confused with healing. Doctors prescribed Vin Mariani because patients returned satisfied. This was feedback closed on subjective sensation—and in 19th century medicine, subjective sensation was often the only criterion.
Cocaine is an alkaloid, poorly soluble in water but excellently soluble in alcohol. When coca leaves were infused in wine, ethanol extracted from them not only cocaine but other alkaloids, tannins, essential oils. The result was a complex extract where cocaine played the lead role but not the only one. Wine masked the bitterness, added its own psychoactive effect, and provided preservation.
But the main trick was different: ethanol didn't just extract cocaine, it enhanced its absorption. Alcohol dilates the vessels of the stomach lining, accelerating the entry of active substances into the blood. Cocaine began acting faster than if it had been swallowed as powder or chewed as leaves. This was a synergistic effect: two psychoactive substances, each amplifying the other.
Mariani didn't publish chemical formulas and didn't reveal the exact technology. He kept the subtleties of the process to himself, surrounding the product with an aura of laboratory secrecy. It's known he used Peruvian coca leaves, considered superior to Bolivian. It's known he infused them for several weeks, periodically shaking. It's known the final concentration of cocaine was controlled—Mariani didn't aim for maximum dose, he aimed for optimal.
Competitors tried to copy Vin Mariani but rarely achieved the same result. The problem wasn't access to coca or wine—the problem was balance. Too little cocaine—the effect is imperceptible. Too much—side effects appear. Mariani found the sweet spot where stimulation felt like a surge of energy, not nervous excitement.
In the 1880s, Vin Mariani was exported to America, Britain, Russia. Each country received a version with slightly higher cocaine concentration, because Mariani believed foreign clients expected a stronger effect. This was marketing disguised as pharmacology: in reality the difference of 1.2 mg per ounce was barely noticeable, but the very fact of an "export version" created an aura of exclusivity.
John Pemberton, a pharmacist from Georgia, saw in Vin Mariani not just an imported product but a business model. In 1885 he released Pemberton's French Wine Coca—a direct analog where coca leaves were infused in wine, and kola nut added caffeine to enhance the stimulating effect. The product was sold as an "intellectual tonic" and "cure for nervous exhaustion."
Pemberton didn't hide his inspiration: the name clearly referenced the European original. Advertising promised "strength, vigor, clarity of mind." The formula worked on the same principle: alcohol extracted alkaloids, cocaine stimulated, caffeine from kola added duration of effect. In an era when patent medicines were freely copied, this was normal practice.
But in 1886, Fulton County, where Atlanta was located, instituted prohibition. Sale of alcoholic beverages was banned, including "medicinal wines." Pemberton faced a choice: either stop production or remove the alcohol. He chose the latter. Wine was replaced with carbonated water. Instead of Bordeaux infusion, he got a syrup diluted with soda right at the pharmacy. Thus Coca-Cola was born.
Important point: early Coca-Cola was not "cocaine-free." Coca leaves remained in the recipe. Cocaine concentration was lower than in Vin Mariani (about 5 mg per glass versus 6 mg per ounce of wine), but the substance was present. Coca-Cola was sold as a tonic, "cure for headache and fatigue." Carbonation simply replaced alcohol as the base—cocaine went nowhere.
Pemberton didn't live to see his invention become an empire. He sold the rights to the formula to Asa Candler in 1888 for $2,300. Candler, a businessman with a nose for marketing, turned the pharmacy syrup into a mass product. But for almost two more decades, Coca-Cola contained traces of cocaine, until pressure from anti-narcotic movements forced the company to switch to completely decocainized extract of coca leaves.
At the beginning of the 20th century, the world began to change. The Pure Food and Drug Act of 1906 in the US required listing on labels the content of alcohol, opium, cocaine, and other narcotic substances. Suddenly products that had been sold as "tonics" for decades came under oversight. By the early 1900s, cocaine in Coca-Cola was reduced to traces, and by 1930 it had disappeared almost entirely—but the company continued using "spent coca leaves," exhausted leaves from which cocaine had already been extracted.
Vin Mariani faced a more serious problem: it was impossible to reform. The product was built on alcohol and coca. Remove one—destroy the balance. Remove both—get Bordeaux wine. In 1914, the Harrison Narcotics Tax Act definitively banned free sale of cocaine in the US. Europe followed America in the following years. And in 1914, Mariani himself died—and, according to the accepted version, his tonic disappeared with him: no one bothered to write down the recipe.
His archive—thousands of testimonials, photographs, advertising posters—remained as a monument to an era when marketing outpaced regulation. Pope Leo XIII, Sarah Bernhardt, Jules Verne—all these names worked because no one demanded proof. An image and a signature were enough.
Coca-Cola survived because it managed to mutate. From pharmaceutical tonic it became a soft drink, where "cola" and "coca" remained in the name but disappeared from the formula. The company hired chemists to develop a process for complete removal of cocaine from leaves while preserving the taste. This was an engineering problem: how to extract everything except one alkaloid.
The world in which Vin Mariani was possible disappeared not because of moral panic or medical discoveries. It disappeared because states learned to regulate chemistry. Labeling, certification, bans—all this turned the pharmacy from an alchemist's shop into a medical institution. Cocaine didn't stop being an effective stimulant. It simply stopped being a legal ingredient in tonics. And along with it disappeared an entire category of products where the boundary between medicine and entertainment didn't yet exist.